## **Core Concept**
The question tests knowledge of the pharmacokinetic properties of statins, specifically their duration of action. Statins are a group of cholesterol-lowering medications that inhibit **HMG-CoA reductase**, a key enzyme in the hepatic synthesis of cholesterol.

## **Why the Correct Answer is Right**
Rosuvastatin, also known by its brand name Crestor, has a long half-life, which allows for once-daily dosing. Its **half-life** ranges from 19 to 20 hours, significantly longer than many other statins. This extended half-life contributes to its classification as the longest-acting statin, making it effective in lowering LDL cholesterol levels over a prolonged period.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Atorvastatin (Lipitor) has a half-life of approximately 14 hours, which, although relatively long among statins, is shorter than that of rosuvastatin.
- **Option B:** Simvastatin (Zocor) has a half-life of about 3 hours, necessitating twice-daily dosing for optimal effect, and is thus not the longest-acting.
- **Option C:** Pravastatin (Pravachol) has a half-life of around 2-3 hours, requiring multiple daily doses and making it one of the shorter-acting statins.

## **Clinical Pearl / High-Yield Fact**
A key clinical point to remember is that the long half-life of **rosuvastatin** allows for **flexible dosing** and potentially better **patient compliance**. However, this does not necessarily translate to a greater efficacy over other statins in all patients, but it does offer a pharmacokinetic advantage.

## **Correct Answer:** D. Rosuvastatin.